Latest News
Press background on PATH
Company profile
PATH is a leader in global health innovation. An international nonprofit organization, we save lives and improve health, especially among women and children. We accelerate innovation across five platforms — vaccines, drugs, diagnostics, devices and system and service innovations — that harness our entrepreneurial insight, scientific and public health expertise and passion for health equity. By mobilizing partners around the world, we take innovation to scale, working alongside countries primarily in Africa and Asia to tackle their greatest health needs. Together, we deliver measurable results that disrupt the cycle of poor health.
 Recent press releases
New Pneumococcal Vaccine from Serum Institute of India Achieves WHO Prequalification

PNEUMOSIL®, a vaccine against a leading cause of deadly childhood pneumonia - the pneumococcus bacterium - has achieved prequalification by the World Health Organization (WHO). Developed through a collaboration spanning over a decade between Serum Institute of India, Pvt., Ltd. (SIIPL)... (more)
Share
Global Rotavirus Vaccine Options Expand with World Health Organization Prequalification of New Vaccine from India

PATH welcomes the World Health Organization’s (WHO’s) prequalification of the thermostable rotavirus vaccine, ROTASIIL®, manufactured by Serum Institute of India. The vaccine, which prevents severe rotavirus-induced diarrhea in infants, provides an innovative and affordable... (more)
Share
First Vaccine Carrier Approved by World Health Organization to Prevent Vaccine Freezing during Transport Commercially Available

This week, the first commercially available freeze-free vaccine carrier will begin introductory field trials in Nepal. This follows the World Health Organization (WHO) announcement that the Indian-made carrier using PATH’s “Freeze-Safe” reference design passed WHO Performa... (more)
Share
सीरम इंस्टीट्यूट के टीके ने दिखाया गंभीर रोटावाइरस गैस्ट्रोएंट्राइटिस के विरुद्ध उल्लेखनीय प्रभाव

सीरम इंस्टीट्यूट ऑफ इंडिया प्रा. लि. के रोटावाइरस टीके बीआरवी-पीवी (जिसे रोटासिल® के नाम से जाना जाता है) के भारà... (more)
Share
Serum Institute’s Vaccine Demonstrates Significant Efficacy Against Severe Rotavirus Gastroenteritis

Results from a Phase 3 efficacy study in India of the Serum Institute of India Pvt. Ltd.’s rotavirus vaccine BRV-PV (known as ROTASIIL®) were published in the journal Vaccine. The study showed the vaccine to be safe, well tolerated, and to provide significant efficacy against seve... (more)
Share
Integrating Prevention and Treatment Tools to Fight Diarrhea

PATH’s Defeat Diarrheal Disease Initiative (DefeatDD) convened thought leaders in New Delhi on July 26, at an event titled, “Defeating diarrhea: integration is the solution,” to deliberate on child health in India and the challenges that India faces in tackling diarrh... (more)
Share
Defeating Diarrhea: Integration is the Solution

Tomorrow, July 26, at 3:00 p.m. in Tamarind Hall at India Habitat Centre, PATH’s Defeat Diarrheal Disease Initiative (DefeatDD) will convene thought leaders on child health in India at an event titled,“Defeating diarrhea: Integration is the solution.”On the occasion, Dr. G... (more)
Share
Consultation Discusses Need for Sustainable and Scalable Solutions for Menstrual Hygiene Management in India

Thought provoking and possible game changing discussions on access, use, disposal and treatment of menstrual hygiene products in India were presented at the one day consultation: Pushing the Boundaries on the MHM Dialogue held here today.
 
... (more)
Share